chr22-40346495-C-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The ENST00000623632.4(ADSL):​c.-64C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000292 in 1,532,308 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 5 hom. )

Consequence

ADSL
ENST00000623632.4 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -0.120

Publications

0 publications found
Variant links:
Genes affected
ADSL (HGNC:291): (adenylosuccinate lyase) The protein encoded by this gene belongs to the lyase 1 family. It is an essential enzyme involved in purine metabolism, and catalyzes two non-sequential reactions in the de novo purine biosynthetic pathway: the conversion of succinylaminoimidazole carboxamide ribotide (SAICAR) to aminoimidazole carboxamide ribotide (AICAR) and the conversion of adenylosuccinate (S-AMP) to adenosine monophosphate (AMP). Mutations in this gene are associated with adenylosuccinase deficiency (ADSLD), a disorder marked with psychomotor retardation, epilepsy or autistic features. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
ADSL Gene-Disease associations (from GenCC):
  • adenylosuccinate lyase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.00031 (428/1379952) while in subpopulation SAS AF = 0.00469 (374/79780). AF 95% confidence interval is 0.0043. There are 5 homozygotes in GnomAdExome4. There are 308 alleles in the male GnomAdExome4 subpopulation. Median coverage is 28. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000623632.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADSL
NM_000026.4
MANE Select
c.-64C>A
upstream_gene
N/ANP_000017.1X5D8S6
ADSL
NM_001410812.1
c.-64C>A
upstream_gene
N/ANP_001397741.1A0A7P0Z472
ADSL
NM_001363840.3
c.-64C>A
upstream_gene
N/ANP_001350769.1A0A1B0GWJ0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADSL
ENST00000623632.4
TSL:5
c.-64C>A
5_prime_UTR
Exon 1 of 10ENSP00000485288.2A0A096LNY5
ADSL
ENST00000623063.3
TSL:1 MANE Select
c.-64C>A
upstream_gene
N/AENSP00000485525.1P30566-1
ADSL
ENST00000342312.9
TSL:1
c.-64C>A
upstream_gene
N/AENSP00000341429.6P30566-2

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152238
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000478
GnomAD4 exome
AF:
0.000310
AC:
428
AN:
1379952
Hom.:
5
Cov.:
28
AF XY:
0.000452
AC XY:
308
AN XY:
682058
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31900
American (AMR)
AF:
0.00
AC:
0
AN:
36968
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25208
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36698
South Asian (SAS)
AF:
0.00469
AC:
374
AN:
79780
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37396
Middle Eastern (MID)
AF:
0.000982
AC:
5
AN:
5092
European-Non Finnish (NFE)
AF:
0.0000252
AC:
27
AN:
1069352
Other (OTH)
AF:
0.000382
AC:
22
AN:
57558
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
21
42
63
84
105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152356
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41582
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00331
AC:
16
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68042
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Adenylosuccinate lyase deficiency (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
9.9
DANN
Benign
0.80
PhyloP100
-0.12
PromoterAI
-0.091
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs576843830; hg19: chr22-40742499; API